Related references
Note: Only part of the references are listed.Synthesis of Gentamicin Minor Components: Gentamicin B1 and Gentamicin X2
Parasuraman Rajasekaran et al.
ORGANIC LETTERS (2020)
2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides
Safwat M. Rabea et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis
Emma J. Brasell et al.
PLOS ONE (2019)
Immunohistochemical localization of megalin and cubilin in the human inner ear
Seiji Hosokawa et al.
BRAIN RESEARCH (2018)
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
Westley J. Friesen et al.
PLOS ONE (2018)
Genetic therapies for inherited neuromuscular disorders
Mariacristina Scoto et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Structure-Based Design and Synthesis of Apramycin-Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series
Appi Reddy Mandhapati et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)
Kerstin Nagel-Wolfrum et al.
BIODRUGS (2016)
Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations
Narayana Murthy Sabbavarapu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Designer aminoglycosides prevent cochlear hair cell loss and hearing loss
Markus E. Huth et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways
Junya Nagai et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Structural basis for the inhibition of the eukaryotic ribosome
Nicolas Garreau de Loubresse et al.
NATURE (2014)
Gentamicin Binds to the Megalin Receptor as a Competitive Inhibitor Using the Common Ligand Binding Motif of Complement Type Repeats INSIGHT FROM THE NMR STRUCTURE OF THE 10TH COMPLEMENT TYPE REPEAT DOMAIN ALONE AND IN COMPLEX WITH GENTAMICIN
Robert Dagil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations
Jeyakumar Kandasamy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
New developments in aminoglycoside therapy and ototoxicity
Jing Xie et al.
HEARING RESEARCH (2011)
Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
Celia Floquet et al.
NUCLEIC ACIDS RESEARCH (2011)
An Integrative Overview on the Mechanisms Underlying the Renal Tubular Cytotoxicity of Gentamicin
Yaremi Quiros et al.
TOXICOLOGICAL SCIENCES (2011)
Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations
Jeyakumar Kandasamy et al.
MEDCHEMCOMM (2011)
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Cubilin and Megalin Co-Localize in the Neonatal Inner Ear
Jacob Tauris et al.
AUDIOLOGY AND NEURO-OTOLOGY (2009)
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
Igor Nudelman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure-toxicity relationship of aminoglycosides:: Correlation of 2′-amine basicity with acute toxicity in pseudo-disaccharide scaffolds
Lilach Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
A meta-analysis of nonsense mutations causing human genetic disease
Matthew Mort et al.
HUMAN MUTATION (2008)
Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases
Mariana Hainrichson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Tuning the regioselectivity of the staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification
J Li et al.
ORGANIC LETTERS (2005)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
Selective electrochemical glycosylation by reactivity tuning
RR France et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Total synthesis of desferrisalmycin B
L Dong et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Novel 2,5-dideoxystreptamine derivatives targeting the ribosomal decoding site RNA
D Vourloumis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene
M Du et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Role of megalin in renal handling of aminoglycosides
J Nagai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
JP Clancy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Efficient synthesis of neomycin B related aminoglycosides
YL Ding et al.
TETRAHEDRON LETTERS (2000)
Share Paper
